BRIEF

on MONOGRAM ORTHOPAEDICS INC (NASDAQ:MGRM)

Monogram Technologies Upsizes 8.00% Series D Convertible Preferred Stock and Warrant Offering to $12.5 Million

Stock price chart of MONOGRAM ORTHOPAEDICS INC (EBR:MGRM) showing fluctuations.

AUSTIN, TX / ACCESSWIRE / September 11, 2024 / Monogram Technologies Inc. (NASDAQ:MGRM) announced an increase in its continuous offering units, from $10 million to $12.5 million. Each unit includes one share of 8.00% Series D Convertible Cumulative Preferred Stock and one common stock purchase warrant for one share of common stock.

The units will not be certified or issued as standalone securities. Warrants become exercisable after 180 days from July 9, 2024, through July 8, 2025, at an exercise price of $3.375 per share. Shares of the Series D Preferred Stock and warrants will be separable and tradable immediately.

Conversion of each Series D Preferred Stock to a common share is at the holder's discretion. Monogram will not list the Series D Preferred Stock or warrants on national exchanges. Proceeds will fund corporate needs, technology development, and potential acquisitions.

CEO Benjamin Sexson stated, “These funds will provide us with additional resources to support key initiatives as we continue to innovate within the orthopedic market.” The offering requires customary closing conditions and will end on September 12th at midnight PT.

R. H.

Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all MONOGRAM ORTHOPAEDICS INC news